Abstract
Ductal carcinoma in situ (DCIS) of the breast is a noninvasive breast cancer that encompasses a wide spectrum of diseases, ranging from low-grade lesions that are not life threatening to high-grade lesions that may harbor foci of invasive breast cancer; its histological characteristic is the proliferation of malignant epithelial cells that are bound by the basement membrane of the breast ducts [1], which implies no stromal invasion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102:170–178
Leonard GD, Swain SM (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96:906–920
Gillis DA, Dockerty MB, Clagett OT (1960) Preinvasive intraductal carcinoma of the breast. Surg Gynecol Obstet 110:555–562
Lee RJ, Vallow LA, McLaughlin SA et al (2012) Ductal carcinoma in situ of the breast. doi:10.1155/2012/123549
Lambert K, Patani N, Mokbel K (2012) Ductal carcinoma in situ: Recent advances and future prospects. International Journal of Surgical Oncology. doi:10.1155/2012/347385
Miller FR, Soule HD, Tait L et al (1993) Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 85:1725–1732
Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272–278
Silverstein MJ (1999) Ductal carcinoma in situ of the breast: A surgeon’s disease. Annals of Surgical Oncology 6:802–810
Silverstein MJ, Poller DN, Waisman JR et al (1995) Prognostic classification of breast ductal carcinoma in situ. Lancet 345:1154–1157
Tavassoli FA (1998) Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140–54
Poller DN, Silverstein MJ, Galea M et al (1994) Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erB-2 protein expression. Mod Pathol 7:257–262
Badve S, A’Hern RP, Ward AM et al (1998) Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. Hum Pathol 29:915–923
Pinder S, Duggan C, Ellis I et al (2010) A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. British Journal of Cancer 103:94–100
Skinner KA, Silverstein MJ (2001) The management of ductal carcinoma in situ of the breast. Endocrine-Related Cancer 8:33–45
Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in-situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103:2481–2484
Kumar S, Sacchini V (2010) The surgical management of ductal carcinoma in situ. The Breast Journal 16:49–52
Choi DX, Van Zee KJ (2012) Memorial Sloan-Kettering Cancer Center: Two decades of experience with ductal carcinoma in situ of the breast. International Journal of Surgical Oncology. doi:10.1155/2012/723916
Holland R, Hendriks JHCL, Verbeek ALM et al (1990) Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ. Lancet 335:519–522
Kurniawan ED, Rose A, Mou A et al (2010) Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. Arch Surg 145:1098–1104
Vicini FA, Recht A (2002) Age at diagnosis and outcome for women with ductal carcinoma in-situ of the breast: a critical review of the literature. Journal of Clinical Oncology 20: 2736–2744
Dick AW, Sorbero MS, Ahrendt GM et al (2011) Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. J Nat Cancer Inst 103:92–104
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 41:162–177
Patani N, Khaled Y, Al Reefy S, Kefah Mokbel (2011) Ductal carcinoma in-situ: An update for clinical practice. Surgical Oncology 20:23–31
Holland R, Velig SHJ, Mravunac M, Hendriks JHCL (1985) Histologic Multifocality of Tis, T 1-2 Breast Carcinomas. Cancer 56:979–990
Kropcho LC, Steen ST, Chung AP et al (2012) Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ. Breast J 18:151–156
Sardanelli F, Bacigalupo L, Carbonaro L et al (2008) What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard? Radiologia Medica 113:439–451
Liberman L, Morris EA, Dershaw DD et al (2003) MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. Am J of Roentgenology 180:901–910
Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group. European Journal of Cancer 46:1296–1316
Kuhl CK (2007) Current Status of Breast MR Imaging. Part 2. Clinical Applications. Radiology 244:672–691
Mariscal MartĂnez A, SolĂ M, PĂ©rez de Tudela A et al (2009) Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. AJR 193:1001–1009
Rose A, Collins JP, Neerhut P et al GB (2003) Carbon localisation of impalpable breast lesions. The Breast 12:264–269
McGhan LJ, McKeever SC, Pockaj BA et al (2011) Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann Surg Oncol 18:3096–3101
Dunne C, Burke JP, Morrow M, Kell MR (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. Journal of Clinical Oncology 27:1615–1620
Solin LJ (2010) The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 41:187–192
Fisher ER, Dignam J, Tan-Chiu E et al (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86:429–438
Rudloff U, Jacks LM, Goldberg JI et al (2010) Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 23:3762–3769
Wang SY, Shamliyan T, Virnig BA, Kane R (2011) Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat 127:1–14
Silverstein MJ, Lagios, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455–1461
Kaufmann M, Morrow M, von Minckwitz G, Harris JR, and The Biedenkopf Expert Panel Members (2010) Locoregional treatment of primary breast cancer. Cancer 116:1184–1191
Morrow M (2009) Breast conservation and negative margins: how much is enough? Breast 18:84–86
Wang SY, Chu H, Shamliyan T et al (2012) Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst 104:507–516
Azu M, Abrahamse P, Katz SJ et al (2010) What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol 17:558–563
McCahill LE, Single RM, Aiello Bowles EJ et al (2012) Variability in reexcision following breast conservation surgery. JAMA 307:467–475
Morrow M, Harris JR, Schnitt SJ (2012) Surgical margins in lumpectomy for breast cancer — bigger is not better. N Engl J Med 367:79–82
Morrow M, Jagsi R, Alderman AK et al (2009) Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302:1551–1556
Clough KB, Kaufman GJ, Nos C et al (2010) Improving breast cancer surgery: A classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol 17:1375–1391
Reedijk M, Hodgson N, Gohla G et al (2012) A prospective study of tumor and technical factors associated with positive margins in breast-conservation therapy for nonpalpable malignancy. Am J Surg 204:263–268
Thill M, Röder K, Diedrich K, Dittmer C (2011) Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. The Breast 20:579–580
McLaughlin SA, Ochoa-Frongia LM, Patil SM et al (2008) Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. J Am Coll Surg 206:76–82
Zafrani B, Contesso G, Eusebi V et al (1995) Guidelines for the pathological management of mammographically detected breast lesions. Breast 4:52–56
Lee CH, Carter D (1995) Detecting residual tumor after excisional biopsy of impalpable breast carcinoma: efficacy of comparing preoperative mammograms with radiographs of the biopsy specimen. AJR Am J Roentgenol 164:81–86
Boyages J, Delaney G, Taylor R (1999) Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 85:616–628
Childs SK, Chen YH, Duggan MM et al (2013) Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ. Int J Radiation Oncol Biol Phys 85:948–952
Carlson GW, Page A, Johnson E et al (2007) Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy. J Am Coll Surg 204:1074–1080
Voltura AM, Tsangaris TN, Rosson GD et al (2008) Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteria. Ann Surg Oncol 15:3396–3401
Cody HS 3rd. (2007) Sentinel lymph node biopsy for DCIS: Are we approaching consensus? Annals of Surgical Oncology 14:2179–2181
Jackman RJ, Burbank F, Parker SH et al (2001) Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218:497–502
Schulz S, Sinn P, Golatta M et al (2012) Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy. Breast doi: 10.1016/j.breast.2012.11.002
Klauber-DeMore N, Tan LK, Liberman L et al (2000) Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7:636–642
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Buggi, F., Mingozzi, M., Rossi, C., Curcio, A., Folli, S. (2014). Surgery for Ductal Carcinoma In Situ (DCIS). In: Mariotti, C. (eds) Oncologic Breast Surgery. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5438-7_7
Download citation
DOI: https://doi.org/10.1007/978-88-470-5438-7_7
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5437-0
Online ISBN: 978-88-470-5438-7
eBook Packages: MedicineMedicine (R0)